METHYLPREDNISOLONE VIATRIS 1 g

DRUG2 trials

Sponsors

GIE Groupe hospitalier Paris Saint-Joseph/Vinci, Spur Therapeutics Limited

Conditions

Gaucher Disease Type 1IDIOPATHIC PULMONARY FIBROSIS

Phase 2

Glucocorticoids versus placebo for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a randomized controlled trial

Not yet recruitingCTIS2024-514799-42-00

GIE Groupe hospitalier Paris Saint-Joseph/VinciIDIOPATHIC PULMONARY FIBROSIS

Target: 110Updated: 2025-08-04

Phase 3

A Phase 3 Safety and Efficacy Trial of FLT201 Gene Therapy in Patients with Gaucher Disease Type 1

Not yet recruitingCTIS2025-520765-50-00

Spur Therapeutics LimitedGaucher Disease Type 1

Target: 4Updated: 2026-09-08